Cargando…
Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020
BACKGROUND: On March 13, 2020, Uganda instituted COVID-19 symptom screening at its international airport, isolation and SARS-CoV-2 testing for symptomatic persons, and mandatory 14-day quarantine and testing of persons traveling through or from high-risk countries. On March 21, 2020, Uganda reported...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686950/ https://www.ncbi.nlm.nih.gov/pubmed/33239041 http://dx.doi.org/10.1186/s12992-020-00643-7 |
_version_ | 1783613431180427264 |
---|---|
author | Migisha, Richard Kwesiga, Benon Mirembe, Bernadette Basuta Amanya, Geofrey Kabwama, Steven N. Kadobera, Daniel Bulage, Lilian Nsereko, Godfrey Wadunde, Ignatius Tindyebwa, Tonny Lubwama, Bernard Kagirita, Atek A. Kayiwa, John T. Lutwama, Julius J. Boore, Amy L. Harris, Julie R. Bosa, Henry Kyobe Ario, Alex Riolexus |
author_facet | Migisha, Richard Kwesiga, Benon Mirembe, Bernadette Basuta Amanya, Geofrey Kabwama, Steven N. Kadobera, Daniel Bulage, Lilian Nsereko, Godfrey Wadunde, Ignatius Tindyebwa, Tonny Lubwama, Bernard Kagirita, Atek A. Kayiwa, John T. Lutwama, Julius J. Boore, Amy L. Harris, Julie R. Bosa, Henry Kyobe Ario, Alex Riolexus |
author_sort | Migisha, Richard |
collection | PubMed |
description | BACKGROUND: On March 13, 2020, Uganda instituted COVID-19 symptom screening at its international airport, isolation and SARS-CoV-2 testing for symptomatic persons, and mandatory 14-day quarantine and testing of persons traveling through or from high-risk countries. On March 21, 2020, Uganda reported its first SARS-CoV-2 infection in a symptomatic traveler from Dubai. By April 12, 2020, 54 cases and 1257 contacts were identified. We describe the epidemiological, clinical, and transmission characteristics of these cases. METHODS: A confirmed case was laboratory-confirmed SARS-CoV-2 infection during March 21–April 12, 2020 in a resident of or traveler to Uganda. We reviewed case-person files and interviewed case-persons at isolation centers. We identified infected contacts from contact tracing records. RESULTS: Mean case-person age was 35 (±16) years; 34 (63%) were male. Forty-five (83%) had recently traveled internationally (‘imported cases’), five (9.3%) were known contacts of travelers, and four (7.4%) were community cases. Of the 45 imported cases, only one (2.2%) was symptomatic at entry. Among all case-persons, 29 (54%) were symptomatic at testing and five (9.3%) were pre-symptomatic. Among the 34 (63%) case-persons who were ever symptomatic, all had mild disease: 16 (47%) had fever, 13 (38%) reported headache, and 10 (29%) reported cough. Fifteen (28%) case-persons had underlying conditions, including three persons with HIV. An average of 31 contacts (range, 4–130) were identified per case-person. Five (10%) case-persons, all symptomatic, infected one contact each. CONCLUSION: The first 54 case-persons with SARS-CoV-2 infection in Uganda primarily comprised incoming air travelers with asymptomatic or mild disease. Disease would likely not have been detected in these persons without the targeted testing interventions implemented in Uganda. Transmission was low among symptomatic persons and nonexistent from asymptomatic persons. Routine, systematic screening of travelers and at-risk persons, and thorough contact tracing will be needed for Uganda to maintain epidemic control. |
format | Online Article Text |
id | pubmed-7686950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76869502020-11-25 Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020 Migisha, Richard Kwesiga, Benon Mirembe, Bernadette Basuta Amanya, Geofrey Kabwama, Steven N. Kadobera, Daniel Bulage, Lilian Nsereko, Godfrey Wadunde, Ignatius Tindyebwa, Tonny Lubwama, Bernard Kagirita, Atek A. Kayiwa, John T. Lutwama, Julius J. Boore, Amy L. Harris, Julie R. Bosa, Henry Kyobe Ario, Alex Riolexus Global Health Research BACKGROUND: On March 13, 2020, Uganda instituted COVID-19 symptom screening at its international airport, isolation and SARS-CoV-2 testing for symptomatic persons, and mandatory 14-day quarantine and testing of persons traveling through or from high-risk countries. On March 21, 2020, Uganda reported its first SARS-CoV-2 infection in a symptomatic traveler from Dubai. By April 12, 2020, 54 cases and 1257 contacts were identified. We describe the epidemiological, clinical, and transmission characteristics of these cases. METHODS: A confirmed case was laboratory-confirmed SARS-CoV-2 infection during March 21–April 12, 2020 in a resident of or traveler to Uganda. We reviewed case-person files and interviewed case-persons at isolation centers. We identified infected contacts from contact tracing records. RESULTS: Mean case-person age was 35 (±16) years; 34 (63%) were male. Forty-five (83%) had recently traveled internationally (‘imported cases’), five (9.3%) were known contacts of travelers, and four (7.4%) were community cases. Of the 45 imported cases, only one (2.2%) was symptomatic at entry. Among all case-persons, 29 (54%) were symptomatic at testing and five (9.3%) were pre-symptomatic. Among the 34 (63%) case-persons who were ever symptomatic, all had mild disease: 16 (47%) had fever, 13 (38%) reported headache, and 10 (29%) reported cough. Fifteen (28%) case-persons had underlying conditions, including three persons with HIV. An average of 31 contacts (range, 4–130) were identified per case-person. Five (10%) case-persons, all symptomatic, infected one contact each. CONCLUSION: The first 54 case-persons with SARS-CoV-2 infection in Uganda primarily comprised incoming air travelers with asymptomatic or mild disease. Disease would likely not have been detected in these persons without the targeted testing interventions implemented in Uganda. Transmission was low among symptomatic persons and nonexistent from asymptomatic persons. Routine, systematic screening of travelers and at-risk persons, and thorough contact tracing will be needed for Uganda to maintain epidemic control. BioMed Central 2020-11-25 /pmc/articles/PMC7686950/ /pubmed/33239041 http://dx.doi.org/10.1186/s12992-020-00643-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Migisha, Richard Kwesiga, Benon Mirembe, Bernadette Basuta Amanya, Geofrey Kabwama, Steven N. Kadobera, Daniel Bulage, Lilian Nsereko, Godfrey Wadunde, Ignatius Tindyebwa, Tonny Lubwama, Bernard Kagirita, Atek A. Kayiwa, John T. Lutwama, Julius J. Boore, Amy L. Harris, Julie R. Bosa, Henry Kyobe Ario, Alex Riolexus Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020 |
title | Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020 |
title_full | Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020 |
title_fullStr | Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020 |
title_full_unstemmed | Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020 |
title_short | Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020 |
title_sort | early cases of sars-cov-2 infection in uganda: epidemiology and lessons learned from risk-based testing approaches – march-april 2020 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686950/ https://www.ncbi.nlm.nih.gov/pubmed/33239041 http://dx.doi.org/10.1186/s12992-020-00643-7 |
work_keys_str_mv | AT migisharichard earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT kwesigabenon earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT mirembebernadettebasuta earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT amanyageofrey earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT kabwamastevenn earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT kadoberadaniel earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT bulagelilian earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT nserekogodfrey earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT wadundeignatius earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT tindyebwatonny earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT lubwamabernard earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT kagiritaateka earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT kayiwajohnt earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT lutwamajuliusj earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT booreamyl earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT harrisjulier earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT bosahenrykyobe earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 AT arioalexriolexus earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020 |